AALBERTS NV (AALB.AS)       44.47  +0.14 (+0.32%)

44.47  +0.14 (+0.32%)

NL0000852564 - Common Stock


Fundamental Rating

We assign a fundamental rating of 7 out of 10 to AALB. AALB was compared to 43 industry peers in the Machinery industry. While AALB has a great profitability rating, there are some minor concerns on its financial health. AALB has a correct valuation and a medium growth rate.




Profitability

Profitability Rating


AALB's Return On Assets of 9.85% is amongst the best returns of the industry. AALB outperforms 92% of its industry peers. The industry average Return On Assets is 1.49%.
AALB's Return On Equity of 16.80% is amongst the best returns of the industry. AALB outperforms 84% of its industry peers. The industry average return on equity is 10.15%.

AALB's Profit Margin of 12.09% is amongst the best returns of the industry. AALB outperforms 92% of its industry peers. The industry average Profit Margin is 2.35%.
The Piotroski-F score of AALB is 7.00. This is a strong score and indicates good health and profitability for AALB.
VS Industry

ROA (9.85%) VS Industry: 92% outperformed.

-159.11
15.78

ROE (16.8%) VS Industry: 84% outperformed.

0.56
77.92

Profit Margin (12.09%) VS Industry: 92% outperformed.

-6,110.25
25.92

Valuation

Valuation Rating


AALB's Price/Earning Ratio is a bit cheaper than the industry average which is at 18.02.
The low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The Price/Earnings Ratio is 13.81, which indicates a correct valuation of AALB.
With a Forward Price/Earnings Ratio of 14.86, AALB is valued correctly.

With a price book ratio of 2.29, AALB is valued correctly.
When comparing the price book ratio of AALB to the average industry price book ratio of 1.98, AALB is valued in line with its industry peers.
When comparing the Enterprise Value to EBITDA ratio of AALB to the average industry ratio of 7.57, AALB is valued in line with its industry peers.
VS Industry

Price/Earnings (13.81) VS Industry: 68% outperformed.

250.00
6.62

Price/Book (2.29) VS Industry: 42% outperformed.

71.02
0.56

Enterprise Value/ EBITDA (7.49) VS Industry: 54% outperformed.

637.14
2.94

Growth

Growth Rating


AALB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 156.91%, which is quite impressive.
The Earnings Per Share has been growing by 14.50% on average over the past 5 years. This is quite good.
Looking at the last year, AALB shows a quite strong growth in Revenue. The Revenue has grown by 14.12% in the last year.
When comparing the Revenue growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.

Based on estimates for the next 5 years, AALB will show a small growth in Earnings Per Share. The EPS will grow by 8.56% on average per year.
Measured over the past 5 years, AALB shows a small growth in Revenue. The Revenue has been growing by 3.39% on average per year.
AALB is expected to show a small growth in Revenue. In the coming 5 years, the Revenue will grow by 4.23% yearly.
The EPS growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS14.5% 40.2% 156.91% 15.12% 10.05% 9.98% 8.56%
Revenue3.39% 2.59% 14.12% 3.51% 4.25% 4.45% 4.23%

Health

Health Rating


When comparing the Debt to Equity Ratio of 0.15 to an average industry Debt to Equity of 0.41, AALB is way less dependent on financing that its industry peers.
AALB has an Altman-Z score of 4.04. This indicates that AALB is financially healthy and little risk of bankruptcy at the moment.
The Altman-Z score of AALB is much better than the industry average of 2.05. AALB has a better rating than 84% of its industry peers.
AALB has a good Piotroski-F score of 7.00. This indicates a good health and good profitability for AALB.

AALB has a Current Ratio of 1.26. This is a normal value and indicates that AALB is financially healthy and should not expect problems in meeting its short term obligations.
Compared to an average industry Current Ratio of 1.46, AALB is worse placed to pay its short term obligations than its industry peers.
A Quick Ratio of 0.54 indicates that AALB may have some problems paying its short term obligations.
Compared to an average industry Quick Ratio of 1.09, AALB is worse placed to pay its short term obligations than its industry peers. 96% of its industry peers have a better Quick Ratio.
VS Industry

Debt/Equity (0.15) VS Industry: 76% outperformed.

6.38
-1.80

Quick Ratio (0.54) VS Industry: 4% outperformed.

0.45
24.87

Current Ratio (1.26) VS Industry: 24% outperformed.

0.75
25.35

Altman-Z (4.04) VS Industry: 84% outperformed.

-11.35
47.91

Dividend

Dividend Rating


AALB's Dividend Yield is rather good when compared to the industry average which is at 2.77. AALB pays more dividend than 90% of the companies in the same industry.
AALB's Dividend Yield is rather good when compared to the S&P500 average which is at 2.14.
The dividend of AALB is nicely growing with an annual growth rate of 30.06%!

18.44% of the earnings are spent on dividend by AALB. This is a low number and sustainable payout ratio.
With a Yearly Dividend Yield of 3.71%, AALB has a reasonable but not impressive dividend return.
AALB's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
VS Industry

Dividend Yield (3.71%) VS Industry: 90% outperformed.

0.71
4.57
AALB Daily chart

AALBERTS NV44.47

AMS:AALB (5/16/2022, 5:29:45 PM)+0.14 (+0.32%)

Chartmill FA Rating
GICS Sector Industrials
GICS IndustryGroup Capital Goods
GICS Industry Machinery
Earnings (Last) N/A N/A Earnings (Next) N/A N/A
Ins Owners N/A Inst Owners N/A
Market Cap 4.92B Analysts 80
Valuation
PE 13.81 Fwd PE 14.86
PEG (NY) 0.91 PEG (5Y) 0.95
P/S 1.65 P/B 2.29
EV/EBITDA 7.49
Profitability
ROA 9.85% ROE 16.8%
PM 12.09 Asset Turnover 0.82
Growth
EPS 1Y 156.91% EPS 3Y 40.2%
EPS 5Y 14.5% EPS growth Q2Q 251.63%
EPS Next Y 15.12% EPS Next 2Y 10.05%
EPS Next 3Y 9.98% EPS Next 5Y 8.56%
Revenue growth 1Y 14.12% Revenue growth 3Y 2.59%
Revenue growth 5Y 3.39% Revenue growth Q2Q 10.96%
Revenue Next Year 3.51% Revenue Next 2Y 4.25%
Revenue Next 3Y 4.45% Revenue Next 5Y 4.23%
Health
Current Ratio 1.26 Quick Ratio 0.54
Altman-Z 4.04 F-Score 7
Debt/Equity 0.15
Dividend
Dividend Yield 3.71% Dividend Growth 30.06%
DP 18.44% Ex-Date N/A

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the EuroNext

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the EuroNext

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the EuroNext

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the EuroNext